Ketamine controls prolonged status epilepticus

被引:142
作者
Borris, DJ [1 ]
Bertram, EH [1 ]
Kapur, J [1 ]
机构
[1] Univ Virginia, Hlth Sci Ctr, Dept Neurol, Charlottesville, VA 22903 USA
关键词
phenobarbital; ketamine; refractory seizure;
D O I
10.1016/S0920-1211(00)00175-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
New treatments are needed to control prolonged status epilepticus given the high failure rate of current therapies. In an animal model of status epilepticus based on electrical stimulation of the hippocampus, rats demonstrate at least 5 five-hours of seizure activity following stimulation. Phenobarbital (70 mg/kg) administered 15 min after stimulation effectively controlled seizures in 66% of animals (n = 6). When phenobarbital (70 mg/kg) was administered 60 min after stimulation, seizures were controlled in 25% of animals (n=4). Ketamine (100 mg/kg) administered 15 min after stimulation did not control seizures in any animal (n = 4). But when ketamine was administered one hour after stimulation it effectively controlled seizures in all animals (n = 4). Increasing doses of ketamine were administered 60 min after stimulation to generate a dose-response curve. The ketamine dose response (fraction of seizure free rats) data were fit to a sigmoid curve to derive an ED50 of 58 mg/kg. These findings suggest that prolonged status epilepticus becomes refractory to phenobarbital but can be effectively controlled by ketamine. For patients experiencing prolonged status epilepticus that is refractory to phenobarbital, ketamine may be an alternative to general anesthesia. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:117 / 122
页数:6
相关论文
共 50 条
[21]   Ketamine for the treatment of (super) refractory status epilepticus? Not quite yet [J].
Dorandeu, Frederic .
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2017, 17 (05) :419-421
[22]   Literature review, case report, and expert discussion of prolonged refractory status epilepticus [J].
T. K. Robakis ;
L. J. Hirsch .
Neurocritical Care, 2006, 4 :35-46
[23]   Literature review, case report, and expert discussion of prolonged refractory status epilepticus [J].
Robakis, T. K. ;
Hirsch, L. J. .
NEUROCRITICAL CARE, 2006, 4 (01) :35-46
[24]   Intravenous ketamine for the treatment of refractory status epilepticus: A retrospective multicenter study [J].
Gaspard, Nicolas ;
Foreman, Brandon ;
Judd, Lilith M. ;
Brenton, James N. ;
Nathan, Barnett R. ;
McCoy, Blathnaid M. ;
Al-Otaibi, Ali ;
Kilbride, Ronan ;
Fernandez, Ivan Sanchez ;
Mendoza, Lucy ;
Samuel, Sophie ;
Zakaria, Asma ;
Kalamangalam, Giridhar P. ;
Legros, Benjamin ;
Szaflarski, Jerzy P. ;
Loddenkemper, Tobias ;
Hahn, Cecil D. ;
Goodkin, Howard P. ;
Claassen, Jan ;
Hirsch, Lawrence J. ;
LaRoche, Suzette M. .
EPILEPSIA, 2013, 54 (08) :1498-1503
[25]   Ketamine in refractory convulsive status epilepticus in children avoids endotracheal intubation [J].
Ilvento, Lucrezia ;
Rosati, Anna ;
Marini, Carla ;
L'Erario, Manuela ;
Mirabile, Lorenzo ;
Guerrini, Renzo .
EPILEPSY & BEHAVIOR, 2015, 49 :343-346
[26]   Oral ketamine controlled refractory nonconvulsive status epilepticus in an elderly patient [J].
Yeh, Poh-Shiow ;
Shen, Hsiu-Nien ;
Chen, Tai-Yuan .
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2011, 20 (09) :723-726
[27]   Effects of Diazepam and Ketamine on Pilocarpine-Induced Status Epilepticus in Mice [J].
Wang, Siyan ;
Levesque, Maxime ;
Avoli, Massimo .
NEUROSCIENCE, 2019, 421 :112-122
[28]   Ketamine Infusion for Super Refractory Status Epilepticus in Alternating Hemiplegia of Childhood [J].
Samanta, Debopam .
NEUROPEDIATRICS, 2020, 51 (03) :225-228
[29]   Ketamine infusion for refractory status epilepticus: A case report of cardiac arrest [J].
Koffman, Lauren ;
Yiu, Ho Yan ;
Farrokh, Salia ;
Lewin, John, III ;
Geocadin, Romergryko ;
Ziai, Wendy .
JOURNAL OF CLINICAL NEUROSCIENCE, 2018, 47 :149-151
[30]   Midazolam and Ketamine for Convulsive Status Epilepticus in the Out-of-Hospital Setting [J].
Zitek, Tony ;
Scheppke, Kenneth A. ;
Antevy, Peter ;
Coyle, Charles ;
Garay, Sebastian ;
Scheppke, Eric ;
Farcy, David A. .
ANNALS OF EMERGENCY MEDICINE, 2025, 85 (04) :305-312